A growing number of studies using single-cell transcriptomics revealed that neutrophil activity in the inflamed intestine was closely associated with the resistance to therapies such as anti-TNF agents and corticosteroids for IBD (46–48). Here, TNF is linked to inflammatory bowel disease.